Price Alert

Amphastar Pharmaceuticals... (AMPH)

NASDAQ: AMPH · Real-Time Price · USD

30.10

-0.11 (-0.36%)

At close: Aug 15, 2025, 2:17 PM

Amphastar Pharmaceuticals Statistics

Share Statistics

Amphastar Pharmaceuticals has 47.14M shares outstanding. The number of shares has increased by -3.16% in one year.

Shares Outstanding	47.14M
Shares Change (YoY)	-3.16%
Shares Change (QoQ)	-1.07%
Owned by Institutions (%)	69.81%
Shares Floating	34.1M
Failed to Deliver (FTD) Shares	39
FTD / Avg. Volume	0.01%

Short Selling Information

The latest short interest is 4.01M, so 8.5% of the outstanding shares have been sold short.

Short Interest	4.01M
Short % of Shares Out	8.5%
Short % of Float	16.84%
Short Ratio (days to cover)	8.27

Valuation Ratios

The PE ratio is 11.27 and the forward PE ratio is 6.76. Amphastar Pharmaceuticals's PEG ratio is 0.73.

PE Ratio	11.27
Forward PE	6.76
PS Ratio	2.52
Forward PS	1.7
PB Ratio	2.46
P/FCF Ratio	10.43
PEG Ratio	0.73

Financial Ratio History

Enterprise Valuation

Amphastar Pharmaceuticals has an Enterprise Value (EV) of 2.3B.

EV / Sales	3.22
EV / EBITDA	8.28
EV / EBIT	10.77
EV / FCF	13.33

Financial Position

The company has a current ratio of 3.07, with a Debt / Equity ratio of 0.89.

Current Ratio	3.07
Quick Ratio	2.19
Debt / Equity	0.89
Debt / EBITDA	2.35
Debt / FCF	3.77
Interest Coverage	6.77

Financial Efficiency

Return on Equity is 21.78% and Return on Invested Capital is 12.28%.

Return on Equity	21.78%
Return on Assets	10.11%
Return on Invested Capital	12.28%
Revenue Per Employee	$351.49K
Profits Per Employee	$78.66K
Employee Count	2,028
Asset Turnover	0.45
Inventory Turnover	2.2

Taxes

Income Tax	29.67M
Effective Tax Rate	15.64%

Stock Price Statistics

The stock price has increased by -36.65% in the last 52 weeks. The beta is 0.76, so Amphastar Pharmaceuticals's price volatility has been higher than the market average.

Beta	0.76
52-Week Price Change	-36.65%
50-Day Moving Average	23.41
200-Day Moving Average	31.63
Relative Strength Index (RSI)	61.53
Average Volume (20 Days)	508,425

Income Statement

In the last 12 months, Amphastar Pharmaceuticals had revenue of 712.81M and earned 159.52M in profits. Earnings per share was 3.29.

Revenue	712.81M
Gross Profit	373.86M
Operating Income	205.42M
Net Income	159.52M
EBITDA	277.31M
EBIT	220.11M
Earnings Per Share (EPS)	3.29

Full Income Statement

Balance Sheet

The company has 151.61M in cash and 650.55M in debt, giving a net cash position of -498.94M.

Cash & Cash Equivalents	151.61M
Total Debt	650.55M
Net Cash	-498.94M
Retained Earnings	568.79M
Total Assets	1.63B
Working Capital	388.91M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 213.39M and capital expenditures -41.04M, giving a free cash flow of 172.34M.

Operating Cash Flow	213.39M
Capital Expenditures	-41.04M
Free Cash Flow	172.34M
FCF Per Share	3.56

Full Cash Flow Statement

Margins

Gross margin is 52.45%, with operating and profit margins of 28.82% and 22.38%.

Gross Margin	52.45%
Operating Margin	28.82%
Pretax Margin	26.62%
Profit Margin	22.38%
EBITDA Margin	38.9%
EBIT Margin	28.82%
FCF Margin	24.18%

Dividends & Yields

AMPH does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	8.87%
FCF Yield	9.58%

Dividend Details

Analyst Forecast

The average price target for AMPH is $30, which is 9.5% higher than the current price. The consensus rating is "Hold".

Price Target	$30
Price Target Difference	9.5%
Analyst Consensus	Hold
Analyst Count	4

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	$82.25
Lynch Upside	200.18%
Graham Number	33.48
Graham Upside	22.19%

Scores

Altman Z-Score	2.41
Piotroski F-Score	7